ESPERITE (ESP) updates on the current business.

February 17, 2020 Group News

  17 February 2020

Financial and business update

Esperite update the market

 

Esperite NV (Esperite, The Company) updates its shareholders on the current configuration and business of the company.

The company has taken distance from the operative part of its activities and focus its effort on turning itself in an investment company with a focus on Health Care and High-Tech Service.

***

read more

ESPERITE : Extraordinary General Meeting of Shareholders 26 March 2020

February 13, 2020 Group News , Press Release (ENG)

ESPERITE N.V. convenes Extraordinary General Meeting of Shareholders on 26 March 2020

Amsterdam, The Netherlands – 13 February 2020

***

PDF Downloads – EGM 26 March 2020

           Press Release :  EGM-26-March-2020-Press-Release-1.pdf

          Agenda  :              EGM-26-March-2020-Agenda-1.pdf

          Notice  :                EGM-26-March-2020-Notice-1.pdf

Explanatory Notes :   EGM-26-March-2020-Explanatory-Notes-1.pdf

Power of Attorney :    EGM-26-March-2020-Power-of-Attorney-1.pdf

read more

ESPERITE (ESP) disputes the Court verdict and appeals the order.

October 14, 2019 Group News

ESPERITE (ESP) disputes the Court verdict and appeals the order.

Amsterdam, The Netherlands – 14 October 2019

 

To learn more about the ESPERITE Group, info@esperitegroup.com or visit the website at www.esperite.com,

***

 This press release contains inside information as referred to in article 7 paragraph 1 of Regulation (EU) 596/2014 (Market Abuse Regulation).

 

read more

ESPERITE (N.V) WITH CRYOSAVE ANNOUNCES THE RELEASE OF TWO CORD BLOOD STEM CELLS SAMPLES FOR TREATMENTS AND THEREFORE CONFIRMS THE IMPORTANCE OF STEM CELLS IN THE FIELD OF REGENERATIVE MEDICINE.

July 2, 2019 Group News

ESPERITE (N.V) WITH CRYOSAVE ANNOUNCES THE RELEASE OF TWO CORD BLOOD STEM CELLS SAMPLES FOR TREATMENTS AND THEREFORE CONFIRMS THE IMPORTANCE OF STEM CELLS IN THE FIELD OF REGENERATIVE MEDICINE.

Amsterdam, The Netherlands – 2nd July 2019
read more